Introduction
============

Paraquat (PQ) has been one of the most effective and widely used herbicides over the last few decades, particularly in rural areas of developing countries; however, PQ poisoning has become a serious problem, with reports of mortality \>90% ([@b1-etm-0-0-5677],[@b2-etm-0-0-5677]). The primary pathological effects of PQ are observed in the lung, where pulmonary concentrations are 6--10 times higher than in plasma following PQ ingestion ([@b3-etm-0-0-5677]). Furthermore, PQ accumulates in the lungs as blood levels begin to decrease ([@b3-etm-0-0-5677]). The rapid accumulation of PQ damages the parenchymal cells in the lung and induces the excessive repair of lung tissues, which results in irreversible and extensive pulmonary fibrosis (PF) ([@b3-etm-0-0-5677]) and eventually leads to high mortality rates. However, the exact mechanism that leads to toxicity remains unclear, and no specific therapy has been recommended.

Epithelial-to-mesenchymal transition (EMT) occurs in multiple contexts, including embryonic development, tissue fibrosis, and cancer. EMT is defined as the process by which stationary epithelial cells (identified by high levels of E-cadherin and zonula occludens-1, which are markers of epithelial cells) undergo phenotypic changes, including the loss of cell-cell adhesion and apical-basal polarity, and acquire mesenchymal characteristics, including high levels of α-smooth muscle actin (α-SMA) and N-cadherin (markers of mesenchymal cells), that confer migratory capacity ([@b4-etm-0-0-5677],[@b5-etm-0-0-5677]). According to previous findings, EMT has an important role in the development of PF. Alveolar epithelial cells could acquire mesenchyme cell phenotypes through EMT, these cells could then increase the deposition of extracellular matrix and further promote the development of PF ([@b5-etm-0-0-5677]--[@b7-etm-0-0-5677]). Furthermore, EMT has been demonstrated to serve an important role in PQ-induced PF in recent studies by the present authors ([@b8-etm-0-0-5677],[@b9-etm-0-0-5677]).

Hypoxia-inducible factor-1α (HIF-1α) has roles in tumorigenesis, inflammation, and cell metabolism in hypoxia, and its expression is correlated with a variety of fibrotic diseases ([@b10-etm-0-0-5677],[@b11-etm-0-0-5677]). HIF-1α has also been demonstrated to induce EMT and contribute to PF ([@b12-etm-0-0-5677],[@b13-etm-0-0-5677]). Previous studies have detected an early increase in HIF-1α expression following PQ poisoning and revealed that HIF-1α modulates EMT in cases of PF ([@b9-etm-0-0-5677],[@b14-etm-0-0-5677]).

Lysyl oxidase (LOX) is a secreted copper-dependent amine oxidase that is important for growth, stabilization, remodeling and repair. Its primary function is to catalyze the covalent cross-linking of collagens and elastin in the extracellular matrix, although it also has intracellular functions ([@b15-etm-0-0-5677]). LOX participates in various fibrosis processes, such as lung, myocardial and renal fibrosis ([@b16-etm-0-0-5677]--[@b18-etm-0-0-5677]). As demonstrated in a previous study by the present authors, LOX promotes EMT in PQ-induced PF ([@b8-etm-0-0-5677]). LOX was previously considered a critical target of HIF-1α ([@b19-etm-0-0-5677]); however, HIF-1α and LOX have since been demonstrated to provide bidirectional regulation of colon and ovarian carcinomas ([@b20-etm-0-0-5677],[@b21-etm-0-0-5677]). The potential for dual regulation via HIF-1α and LOX remains controversial, particularly in PQ-induced PF. The present study investigated the association between HIF-1α and LOX with regard to PQ-induced PF.

Materials and methods
=====================

### Reagents

PQ powder was obtained from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Anti-HIF-1α antibodies (cat. no. BS3514) were purchased from Bioworld Technology, Inc. (St. Louis Park, MN, USA). Anti-LOX (cat. no. ab174316), anti-E-cadherin (cat. no. ab184633) and anti-α-SMA (cat. no. ab7817) primary antibodies were obtained from Abcam (Cambridge, MA, USA). Anti-β-catenin (cat. no. 8480) and anti-GAPDH (cat. no. 5174) antibodies were purchased from Cell Signaling Technology, Inc. (Boston, MA, USA). Horseradish peroxidase-conjugated anti-rabbit immunoglobulin (Ig)G (cat. no. A0208), anti-mouse IgG secondary antibodies (cat. no. A0216), immunofluorescence staining kits with Alexa Fluor 647-labeled goat anti-rabbit immunoglobulin G (cat. no. A0468) and kits with Alexa Fluor 488-labeled goat anti-rabbit IgG (cat. no. A0423) were obtained from Beyotime Institute of Biotechnology (Shanghai, China).

### Cell culture

Human lung adenocarcinoma epithelial cells (A549) and rat alveolar type II cells (RLE-6TN) were obtained from the American Type Culture Collection (Manassas, VA, USA). A549 cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) (HyClone; GE Healthcare Life Sciences, Logan, UT, USA) supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and a 1% antibiotic solution (100 U/ml penicillin and 0.1 mg/ml streptomycin). RLE-6TN cells were cultured in DMEM/nutrient mixture F-12 supplemented with 10% FBS and 1% antibiotic solution. Both cell lines were cultured at 37°C in an atmosphere containing 5% CO~2~. Cells were subsequently treated with PQ (at a concentration of 800 µmol/l for A549 cells and 160 µmol/l for RLE-6TN cells) for 24 h at 37°C. These concentrations were used in accordance with a recent study by the present authors ([@b9-etm-0-0-5677]). The effect of HIF-1α or LOX silencing on cells was detected and the expression of other proteins was subsequently assessed using western blotting.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Total RNA was isolated from cells using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.). The total RNA concentration was determined using an ultraviolet spectrophotometer. Reverse transcription was performed using a PrimeScript RT Master Mix kit (Takara Biotechnology Co., Ltd., Dalian, China), according to the manufacturer\'s instructions. Real-time quantitative PCR was performed using a SYBR Premix Ex Taq kit (Takara Biotechnology Co., Ltd.) in a ViiA 7 PCR system. Sangon Biotech Co., Ltd. (Shanghai, China) generated the primers for HIF-1α, LOX, β-catenin and β-actin. Primer sequences are listed in [Table I](#tI-etm-0-0-5677){ref-type="table"}. The thermocycling conditions were as follows: 2 min at 95°C for initial denaturation, followed by 40 amplification cycles consisting of 95°C for 10 sec (denaturation), 60°C for 30 sec (anneal) and 72°C for 30 sec (extension). The method of quantification used was the 2^−ΔΔCq^ method ([@b22-etm-0-0-5677]). Each assay was performed in triplicate, and β-actin served as a loading control.

### Western blotting

Total proteins were harvested from both cell lines in each group and lysed using radioimmunoprecipitation assay buffer (Beyotime Institute of Biotechnology). Protein concentrations were determined using a bicinchoninic acid protein assay kit (Beyotime Institute of Biotechnology). Total protein samples (\~30 µg per lane) were separated via 8% SDS-PAGE (Beyotime Institute of Biotechnology), transferred to polyvinylidene difluoride membranes (Bio-Rad Laboratories, Inc., Hercules, CA, USA), blocked with 5% skimmed milk in Tris-buffered saline containing Tween-20 (TBST) for 90 min at room temperature (RT), and incubated with antibodies against HIF-1α (1:500), LOX (1:1,000), E-cadherin (1:500), α-SMA (1:500), β-catenin (1:1,000) or GAPDH (1:500) overnight at 4°C. Membranes were subsequently incubated with horseradish peroxidase-conjugated anti-rabbit IgG or anti-mouse IgG secondary antibodies (1:2,000; Beyotime Institute of Biotechnology) at RT. Following three washes with TBST, proteins were observed using a highly sensitive enhanced chemiluminescent agent (Thermo Fisher Scientific, Inc.). The band intensity was determined using ImageJ software (version 10.2; National Institutes of Health, Bethesda, MD, USA).

### Immunofluorescence staining

Both cell lines were cultured in confocal dishes for 24 h at 37°C and incubated with PQ for 24 h at 37°C. Cells were washed with PBS, fixed with 4% paraformaldehyde (Sigma-Aldrich; Merck KGaA) for 10 min at RT, permeabilized with 0.5% Triton X100 (Sigma-Aldrich; Merck KgaA) for 10 min and blocked with 5% bovine serum albumin (1 g bovine serum albumin powder and 20 ml Tris-buffered saline; Beyotime Institute of Biotechnology) for 1 h at RT. Subsequently, cells were incubated with anti-LOX (1:100) or anti-HIF-1α (1:50) primary antibodies overnight at 4°C. Following three washes with TBST, cells were incubated with immunofluorescence staining kits with Alexa Fluor 647-labeled goat anti-rabbit IgG (1:200) and kits with Alexa Fluor 488-labeled goat anti-rabbit IgG (1:200) for 1.5 h at RT. Nuclei were stained with DAPI (Beyotime Institute of Biotechnology) for 3 min at RT. Fluorescent signals were detected with a laser confocal scanning microscope (Leica TCS SP8; Leica Microsystems GmbH, Wetzlar, Germany) and the cellular morphology was observed with a phase contrast microscope (AMEX1200, Thermo Fisher Scientific, Inc.) was used to observe the change of cellular morphology.

### Transient transfection

A549 and RLE-6TN cells were cultured in 6-well culture plates as described above and divided into dimethyl sulfoxide groups (including the control, sicontrol, siHIF-1α and siLOX groups) and PQ groups (including the control + PQ, sicontrol + PQ, siHIF-1α + PQ and siLOX + PQ groups). HIF-1α and LOX short interfering (si)RNAs and negative control sequences were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China) and are listed in [Table II](#tII-etm-0-0-5677){ref-type="table"}. For transfection of each siRNA, 4 µl Lipofectamine^®^ 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) were incubated with 100 pmol siRNA or negative control sequences in 500 µl Opti-MEM medium (Gino Biomedical Technology Co., Ltd., Hangzhou, China) for 20 min at RT. Cells were transfected by replacing the medium with 2 ml Opti-MEM medium containing the siRNA or negative control sequences and Lipofectamine^®^ 2000, and then incubating them at 37°C in a humidified atmosphere of 5% CO~2~ for 6 h. The Opti-MEM medium was then replaced with 2 ml fresh culture medium. Subsequently, the cells in the PQ groups were incubated with PQ for 24 h and the other cells were treated with phosphate buffered saline. The total time from the start of transfection to subsequent experimentation was 48 h.

### Statistical analyses

Data were analyzed using SPSS (version 16.0; SPSS, Inc., Chicago, IL, USA) and expressed as the mean + standard deviation of triplicate experiments. Comparisons between two groups were performed using a Student\'s t-test and comparisons of multiple groups were performed using one-way analysis of variance and Dunnett\'s post hoc test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### HIF-1α and LOX may regulate PQ-induced EMT

PQ treatment induced a significant decrease in E-cadherin expression and significantly increased α-SMA expression as determined by western blotting ([Fig. 1A](#f1-etm-0-0-5677){ref-type="fig"}), which confirmed that EMT participated in PQ-induced PF. Protein levels of HIF-1α and LOX were significantly increased in the PQ groups compared with the control groups ([Fig. 1B](#f1-etm-0-0-5677){ref-type="fig"}). Based on the immunofluorescence staining, the levels of HIF-1α and LOX were markedly increased with 24 h of treatment with PQ compared with control groups ([Fig. 1C](#f1-etm-0-0-5677){ref-type="fig"}). These results suggested that EMT served an important role in PQ-induced PF, and that HIF-1α and LOX may regulate EMT following PQ poisoning.

### HIF-1α may promote EMT by upregulating LOX expression

The levels of HIF-1α, LOX- and EMT-related markers in PQ-poisoned A549 and RLE-6TN cells were measured following HIF-1α silencing to determine the potential roles of HIF-1α and LOX in PQ-induced EMT. HIF-1α mRNA expression was significantly decreased in the siHIF-1α + PQ group compared with the sicontrol + PQ group ([Fig. 2A](#f2-etm-0-0-5677){ref-type="fig"}). The expression of EMT markers was reversed following HIF-1α silencing, as α-SMA expression decreased and E-cadherin expression increased ([Fig. 2B](#f2-etm-0-0-5677){ref-type="fig"}). In addition, phase-contrast microscopy revealed that the morphology of cells in the PQ groups changed from a polygon to fusiform morphology compared with the control group. However, these changes were alleviated following HIF-1α silencing ([Fig. 2C](#f2-etm-0-0-5677){ref-type="fig"}). The level of LOX mRNA was significantly decreased in the siHIF-1α + PQ group compared with the sicontrol + PQ group ([Fig. 2D](#f2-etm-0-0-5677){ref-type="fig"}). The protein expression of LOX was reduced in the siHIF-1α + PQ group compared with the sicontrol + PQ group ([Fig. 2E](#f2-etm-0-0-5677){ref-type="fig"}). Therefore, HIF-1α may have an important function in modulating PQ-induced EMT by inducing LOX expression.

### LOX promotes PQ-induced EMT independently from HIF-1α

Levels of HIF-1α, LOX and EMT markers in PQ-poisoned cells following LOX silencing were subsequently determined. The level of LOX mRNA was significantly decreased in the siLOX group compared with the sicontrol group and in the siLOX + PQ group compared with the sicontrol + PQ group ([Fig. 3A](#f3-etm-0-0-5677){ref-type="fig"}). The expression of EMT markers was also reversed following LOX silencing, as α-SMA expression decreased, and E-cadherin increased ([Fig. 3B](#f3-etm-0-0-5677){ref-type="fig"}). In addition, phase-contrast microscopy revealed that the morphological changes (the degree of fusiformity was reduced) observed in cells in the PQ groups were alleviated following LOX silencing ([Fig. 3C](#f3-etm-0-0-5677){ref-type="fig"}). However, the expression of HIF-1α mRNA was not significantly changed in the siLOX + PQ group compared with the sicontrol + PQ group ([Fig. 3D](#f3-etm-0-0-5677){ref-type="fig"}). Levels of HIF-1α protein were also not significantly decreased following LOX expression inhibition ([Fig. 3E](#f3-etm-0-0-5677){ref-type="fig"}). These findings suggest that LOX may promote PQ-induced EMT, but it does not regulate HIF-1α expression.

### HIF-1α may regulate PQ-induced EMT through the LOX/β-catenin pathway

Changes in the levels of β-catenin were detected following HIF-1α (LOX) inhibition *in vitro* to further reveal the interactions between HIF-1α, LOX and β-catenin. β-catenin mRNA levels in the PQ groups were significantly decreased following HIF-1α (LOX) silencing ([Fig. 4A and B](#f4-etm-0-0-5677){ref-type="fig"}). Similar results were observed for the protein expression of β-catenin ([Fig. 4C and D](#f4-etm-0-0-5677){ref-type="fig"}). These findings suggest that HIF-1α may modulate PQ-induced EMT via the LOX/β-catenin pathway.

Discussion
==========

PQ accumulates in the lungs and eventually leads to PF; however, its molecular mechanisms are complex and remain unclear ([@b2-etm-0-0-5677]--[@b4-etm-0-0-5677],[@b7-etm-0-0-5677]). EMT is known to have an important function in PF ([@b4-etm-0-0-5677],[@b7-etm-0-0-5677],[@b23-etm-0-0-5677]). As demonstrated in recent studies by the present authors, EMT occurs in PQ-induced PF and may be modulated by HIF-1α or LOX ([@b8-etm-0-0-5677],[@b9-etm-0-0-5677]). However, the interaction between HIF-1α and LOX remains unclear. Therefore, the association between HIF-1α and LOX was investigated, as was the pathway that regulates PQ-induced EMT. It was demonstrated that HIF-1α may modulate PQ-induced EMT via the LOX/β-catenin pathway.

LOX is a downstream target gene of HIF-1α, and a number of previous gene profiling studies have confirmed that LOX expression is upregulated by HIF-1α ([@b24-etm-0-0-5677]--[@b27-etm-0-0-5677]). LOX is also an important regulator of hypoxia-induced tumor progression in a variety of cancers via a HIF-1α-dependent mechanism ([@b19-etm-0-0-5677],[@b28-etm-0-0-5677]). However, the correlation between HIF-1α and LOX in fibrosis remains unexplored. In the present study, HIF-1α and LOX expression were significantly increased in the model of PQ-induced PF. E-cadherin expression was decreased, and α-SMA expression was significantly increased following PQ treatment, which confirmed that HIF-1α, LOX and EMT are associated with PQ-induced PF. Furthermore, HIF-1α silencing downregulated the expression of LOX mRNA and protein. The expression of EMT markers was also reversed following HIF-1α silencing, as α-SMA expression decreased, and E-cadherin expression increased. In addition, changes in cellular morphology were alleviated following HIF-1α silencing, which indicated that the degree of PQ-induced EMT was alleviated following HIF-1α silencing. Therefore, HIF-1α serves an important role in modulating EMT by activating LOX in PQ-induced PF. This result is consistent with findings from previous studies, which demonstrated that HIF-1α promotes EMT by upregulating LOX expression in ovarian and renal cancers ([@b27-etm-0-0-5677],[@b29-etm-0-0-5677]). It was also confirmed that LOX may be a target of HIF-1α in PQ-induced PF and in tumors by modulating EMT.

In addition to acting as a HIF-1α-responsive gene, LOX may have more complex functions. According to a previous study by Pez *et al* ([@b21-etm-0-0-5677]), LOX and HIF-1α act synergistically to promote colon cancer cell proliferation and tumor formation. As previously demonstrated by Ji *et al* ([@b20-etm-0-0-5677]), LOX silencing downregulates the protein expression of HIF-1α in epithelial ovarian cancer cells. These findings indicated that LOX and HIF-1α may bidirectionally regulate PQ-induced EMT. However, in the present study, LOX silencing did not induce changes in the protein and mRNA levels of HIF-1α. However, the expression of EMT markers was ameliorated following LOX silencing. In addition, changes in cellular morphology were alleviated following LOX silencing. Therefore, the degree of PQ-induced EMT was alleviated following LOX silencing *in vitro*. This finding is consistent with other previously published results ([@b27-etm-0-0-5677],[@b29-etm-0-0-5677]) which reported that LOX inhibition did not prevent HIF-1α upregulation. Furthermore, LOX is only an intermediate signaling molecule that mediates HIF-1α-promoted PQ-induced EMT.

β-catenin is a protein located in cytoplasmic plaques that serves a major role in EMT. β-catenin has been used as a marker of EMT in a number of studies of embryonic development, cancer, and fibrosis ([@b30-etm-0-0-5677]--[@b33-etm-0-0-5677]). According to previous studies, β-catenin is associated with EMT during renal fibrosis ([@b34-etm-0-0-5677]) and fibrosis in other organs ([@b35-etm-0-0-5677],[@b36-etm-0-0-5677]). In addition, β-catenin participates in the development of PF by transforming A549 cells into fibroblasts ([@b23-etm-0-0-5677],[@b37-etm-0-0-5677]). As demonstrated previously, HIF-1α is positively correlated with β-catenin in rat models, and HIF-1α regulates EMT through the β-catenin pathway ([@b9-etm-0-0-5677],[@b38-etm-0-0-5677]). β-catenin mRNA and protein levels were significantly decreased when HIF-1α and LOX were silenced in the present study, which suggests that HIF-1α regulates PQ-induced EMT through the LOX/β-catenin pathway.

The present study aimed to research the role of EMT in the development of PQ-induced pulmonary fibrosis. A549 cells retain the feature of type II alveolar epithelial cells even though they are a type of cancer cell. RLE-6TN cells were type II rat alveolar epithelial cells. These two cell types are widely used to study the mechanism of pulmonary fibrosis, therefore they were each selected for use within the present study to give a more comprehensive investigation. In the present study it was confirmed that EMT served a role in PQ-induced pulmonary fibrosis and may be modulated by HIF-1α or LOX. HIF-1α may modulate PQ-induced EMT via the LOX/β-catenin pathway.

In conclusion, HIF-1α unidirectionally upregulates LOX expression in PQ-induced EMT. The mechanism may be associated with HIF-1α-induced LOX expression, which subsequently increases β-catenin levels, induces EMT and ultimately leads to the development of PQ-induced PF. Therefore, HIF-1α may be a potential target for restraining the development and exacerbation of PF induced by PQ.
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![Levels of the epithelial-to-mesenchymal transition-associated proteins, HIF-1α and LOX, increase during PQ-induced pulmonary fibrosis. (A) E-cadherin, α-SMA and GAPDH levels were detected by western blotting. GAPDH was used as a loading control. (B) HIF-1α, LOX and GAPDH levels were detected by western blotting. (C) Levels of HIF-1α and LOX proteins in A549 and RLE-6TN cells were detected by immunofluorescence staining. Scale bars, 50 µm. Data are presented as the mean + standard deviation (n=3). \*P\<0.05 vs. control. HIF-1α, hypoxia-inducible factor-1α; LOX, lysyl oxidase; PQ, paraquat; α-SMA, α-smooth muscle actin; A, levels in A549 cells; R, levels in RLE-6TN cells.](etm-15-03-2287-g00){#f1-etm-0-0-5677}

![HIF-1α ameliorated the degree of PQ-induced epithelial-to-mesenchymal transition and LOX expression. (A) HIF-1α mRNA levels in HIF-1α-silenced cell lines was detected by RT-qPCR. (B) Protein levels of HIF-1α, E-cadherin, α-SMA and GAPDH were detected by western blotting. GAPDH served as a loading control. (C) Morphological changes were detected using a phase-contrast microscope. Scale bars, 100 µm. (D) The level of LOX mRNA in both HIF-1α-silenced cell lines was detected using RT-qPCR. (E) LOX and GAPDH protein levels were detected by western blotting. ^\$^P\<0.05 vs. control; \*P\<0.05 vs. sicontrol; ^\#^P\<0.05 vs. sicontrol + PQ. HIF-1α, hypoxia-inducible factor-1α; LOX, lysyl oxidase; PQ, paraquat; LOX, lysyl oxidase; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; α-SMA, α-smooth muscle actin; DMSO, dimethyl sulfoxide.](etm-15-03-2287-g01){#f2-etm-0-0-5677}

![LOX reduced the degree of PQ-induced epithelial-to-mesenchymal transition and had no effect on HIF-1α expression. (A) The level of LOX mRNA in both LOX-silenced cell lines was detected by RT-qPCR. (B) Levels of LOX, E-cadherin, α-SMA and GAPDH proteins were detected by western blotting. GAPDH served as a loading control. (C) Morphological changes were detected using a phase-contrast microscope. Scale bars, 100 µm. (D) The level of HIF-1α mRNA in both LOX-silenced cell lines was detected by RT-qPCR. (E) Levels of HIF-1α and GAPDH proteins were detected by western blotting. ^\$^P\<0.05 vs. control; \*P\<0.05 vs. sicontrol; ^\#^P\<0.05 vs. sicontrol + PQ. LOX, lysyl oxidase; PQ, paraquat; HIF-1α, hypoxia-inducible factor-1α; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; α-SMA, α-smooth muscle actin; DMSO, dimethyl sulfoxide.](etm-15-03-2287-g02){#f3-etm-0-0-5677}

![Inhibition of HIF-1α and LOX decreases β-catenin expression *in vitro*. Levels of β-catenin mRNA in (A) HIF-1α- and (B) LOX-silenced A549 and RLE-6TN cells were detected using reverse transcription-quantitative polymerase chain reaction. The expression of β-catenin protein in (C) HIF-1α- and (D) LOX-silenced cells was detected using western blotting. GAPDH served as a loading control. ^\$^P\<0.05 vs. control; \*P\<0.05 vs. sicontrol; ^\#^P\<0.05 vs. sicontrol + PQ. HIF-1α, hypoxia-inducible factor-1α; LOX, lysyl oxidase; DMSO, dimethyl sulfoxide; PQ, paraquat.](etm-15-03-2287-g03){#f4-etm-0-0-5677}

###### 

Primer sequences used in reverse transcription-quantitative polymerase chain reaction.

  Species   Gene (direction)   Sequence (5′-3′)
  --------- ------------------ ------------------------------------
  Human     HIF-1α (F)         GTC TGA GGG GAC AGG AGG AT
            HIF-1α (R)         CTC CTC AGG TGG CTT GTC AG
            LOX (F)            CAA CCT GAG ATG CGC GG
            LOX (R)            GGT CGG CTG GGT AAG AAA TC
            β-catenin (F)      CGT TTC GCC TTC ATT ATG GAC TAC CT
            β-catenin (R)      GCC GCT GGG TGT CCT GAT GT
            β-actin (F)        CTG GAA CGG TGA AGG TGA CA
            β-actin (R)        AAG GGA CTT CCT GTA ACA ATG CA
  Rat       HIF-1α (F)         AAG TCT AGG GAT GCA GCA CG
            HIF-1α (R)         AGA TGG GAG CTC ACG TTG TG
            LOX (F)            CCT ACT ACA TCC AGG CAT CCA
            LOX (R)            AGT CTC TGA CAT CCG CCC TA
            β-catenin (F)      GTG CAA TTC CTG AGC TGA CC
            β-catenin (R)      CGG GCT GTT TCT ACG TCA TT
            β-actin (F)        CCT CTA TGC CAC ACA GT
            β-actin (R)        AGC CAC CAA TCC ACA CAG

HIF-1α, hypoxia-inducible factor-1α; LOX, lysyl oxidase; F, forward; R, reverse.

###### 

Sequences of siRNAs used for transfection.

  Species   siRNA    Sequence (5′-3′)
  --------- -------- --------------------------------
  Human     HIF-1α   F: GCC GAG GAA GAA CUA UGA ATT
                     R: UUC AUA GUU CUU CCU CGG CTT
            LOX      F: CAG GCG AUU UGC AUG UAC UTT
                     R: AGU ACA UGC AAA UCG CCU GTT
  Rat       HIF-1α   F: GGG CCG UUC AAU UUA UGA ATT
                     R: UUC AUA AAU UGA ACG GCC CTT
            LOX      F: CCG GAU GUU AUG AUA CUU ATT
                     R: UAA GUA UCA UAA CAU CCG GTT

Si, silencing; HIF, hypoxia-inducible factor; LOX, lysyl oxidase; F, forward; R, reverse.
